Predicting response to immune checkpoint blockade in recurrent/metastatic head and neck squamous cell carcinoma using personalized circulating tumor DNA

被引：0
|
作者：
Torres, Daniel A. Ruiz
Merkin, Ross D.
Mendel, Julia
Fisch, Adam S.
Roberts, Thomas J.
Patel, Manisha Jayandra
Park, Jong Chul
Chevalier, Amber
Murray, Clodagh
Gates, Lisa
Efthymiou, Vasileios
Pipinikas, Christodoulos
Wirth, Lori J.
Faden, Daniel
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[2] Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[4] NeoGenom Labs Inc, Cambridge, England
[5] NeoGenomics, Cambridge, England
[6] Massachusetts Gen Hosp, Ctr Head & Neck Cancers, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6051
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
    Kim, Dong Hyun
    Kang, Mingu
    Park, Gahee
    Mostafavi, Mohammad
    Lim, Yoojoo
    Ock, Chan-Young
    Koh, Jiwon
    Jeon, Yoon Kyung
    Jung, Kyeong Cheon
    Ahn, Soon-Hyun
    Chung, Eun-Jae
    Kwon, Seong-Keun
    Keam, Bhumsuk
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [22] Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
    Chikuie, Nobuyuki
    Urabe, Yuji
    Ueda, Tsutomu
    Hamamoto, Takao
    Taruya, Takayuki
    Kono, Takashi
    Yumii, Kohei
    Takeno, Sachio
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
    Nobuyuki Chikuie
    Yuji Urabe
    Tsutomu Ueda
    Takao Hamamoto
    Takayuki Taruya
    Takashi Kono
    Kohei Yumii
    Sachio Takeno
    Scientific Reports, 12
  • [24] Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
    Guo, Jhe-Cyuan
    Lin, Chen-Yuan
    Lin, Chia-Chi
    Huang, Ta-Chen
    Lien, Ming-Yu
    Lu, Li-Chun
    Kuo, Hung-Yang
    Hsu, Chih-Hung
    ONCOLOGY, 2021, 99 (10) : 652 - 658
  • [25] Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
    Hanna, Glenn J.
    Liu, Hongye
    Jones, Robert E.
    Bacay, Alyssa F.
    Lizotte, Patrick H.
    Ivanova, Elena V.
    Bittinger, Mark A.
    Cavanaugh, Megan E.
    Rode, Amanda J.
    Schoenfeld, Jonathan D.
    Chau, Nicole G.
    Haddad, Robert I.
    Lorch, Jochen H.
    Wong, Kwok-Kin
    Uppaluri, Ravindra
    Hammerman, Peter S.
    ORAL ONCOLOGY, 2017, 67 : 61 - 69
  • [26] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [28] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [29] Circulating tumor cells as a prognostic factor in recurrent or metastatic head and neck squamous-cell carcinoma: CIRCUTEC study
    Garrel, R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 176 - 177
  • [30] Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study
    Garrel, Renaud
    Mazel, Martine
    Perriard, Francoise
    Vinches, Marie
    Cayrefourcq, Laure
    Guigay, Joel
    Digue, Laurence
    Aubry, Karine
    Alfonsi, Marc
    Delord, Jean-Pierre
    Lallemant, Benjamin
    Even, Caroline
    Daures, Jean-Pierre
    Landais, Paul
    Cupissol, Didier
    Alix-Panabieres, Catherine
    CLINICAL CHEMISTRY, 2019, 65 (10) : 1267 - 1275
12345